CPAP therapy impact in OSA related symptoms – a prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006
Compliance to ventilatory treatment in a cohort of patients on home CPAP or NIV: analysis by diagnosis, treatment type, and comorbidities Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Nasal CPAP in the therapy of OSAS – does a closer patient guidance and support increase compliance? Source: Eur Respir J 2005; 26: Suppl. 49, 707s Year: 2005
Mild OSAS: Is CPAP therapy actually required for these patients? Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Initial acceptance and compliance to nasal CPAP in elderly patients Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011
Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019
The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019
Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020
Can CPAP therapy for paediatric OSA ever be stopped? Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019
Adherence and satisfaction with CPAP therapy among sleep apnea patients: telematic compared with conventional follow-up Source: Sleep and Breathing Conference 2021 Year: 2021
A cross-over study of the efficacy of sildenafil in the treatment of erectile dysfuction (ED) in patients with OSA treated with CPAP Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006
Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS. Source: International Congress 2017 – CPAP therapy Year: 2017
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020 Year: 2020
Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014